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X-ray crystallography of biologically important
RNA molecules has been hampered by techni-
cal challenges, including finding heavy-atom
derivatives to obtain high-quality experimental
phase information. Existing techniques have
drawbacks, limiting the rate at which important
new structures are solved. To address this, we
have developed a reliable means to localize
heavy atoms specifically to virtually any RNA.
By solving the crystal structures of thirteen
variants of the GU wobble pair cation binding
motif, we have identified a version that when
inserted into an RNA helix introduces a high-
occupancy cation binding site suitable for
phasing. This ‘‘directed soaking’’ strategy can
be integrated fully into existing RNA crystallog-
raphy methods, potentially increasing the rate
at which important structures are solved and
facilitating routine solving of structures using
Cu-Ka radiation. This method already has
been used to solve several crystal structures.
INTRODUCTION
The role of RNA in biology is varied and rich, with RNA
playing diverse roles in both healthy and diseased cells.
The function of many biologically important RNAs is
conferred by their three-dimensional folds, and X-ray
crystallography remains the most powerful tool to deter-
mine their structure. While protein crystallography has
progressed to the point where structural genomics efforts
are a reality, RNA crystallography has lagged. This is due
in large part to technical difficulties in rapidly purifying
large amounts of RNA and solving the phase problem
once diffracting crystals are obtained (Doudna, 2000).
Protein crystallography was transformed significantly by
affinity purification techniques (Mondal and Gupta, 2006)
and selenomethionine labeling (Doublie, 1997; Hendrick-
son et al., 1990), which provided generally applicable
strategies for solving protein structures. Analogous tools
for RNA could make RNA crystallography available to
a broad range of researchers. Recently developedStructure 15,methods are addressing the issue of high-throughput
RNA purification (Cheong et al., 2004; Kieft and Batey,
2004; Kim et al., 2007; Lukavsky and Puglisi, 2004); here
we present a general strategy for obtaining phase informa-
tion to solve the crystal structure of potentially any RNA.
Modern techniques to solve crystal structures require
a suitable heavy-atom derivative, yet there is no univer-
sally applicable method for routinely obtaining this. Strat-
egies to obtain diffracting RNA crystals have been
described (Cate and Doudna, 2000; Golden, 2007; Ke
and Doudna, 2004; Wedekind and McKay, 2000), but
obtaining a derivative remains nontrivial (Golden, 2000,
2007). As a result considerable time, effort, and resources
are often spent trying different methods to obtain phase
information. The most traditional means of obtaining an
RNA derivative is to soak many different heavy atoms at
different concentrations into the crystal in an approach
that relies on fortuitous, high-occupancy heavy-atom
binding in specific sites. This method is successful in
many cases but because the presence of suitable sites
in an RNA cannot be predicted or assured, it has been
called ‘‘soak and pray’’ (Golden, 2000; Golden et al.,
1996; Wedekind and McKay, 2000). Other RNA derivatiz-
ing techniques use RNA covalently modified with halo-
gens (e.g., 5-bromouracil) (examples in Baugh et al.,
2000; Kieft et al., 2002; Martick and Scott, 2006), selenium
(Brandt et al., 2006; Carrasco et al., 2004; Hobartner and
Micura, 2004; Hobartner et al., 2005; Jiang et al., 2007;
Salon et al., 2007; Sheng et al., 2007), or other heavy
atoms (Correll et al., 1997), and while covalent derivatiza-
tion methods have been successful they are not suitable
for all RNAs. Another method of obtaining phase informa-
tion is to introduce a protein binding site into the initial
crystallization construct and cocrystallize the RNA with
the selenomethionine-labeled protein once crystals have
been obtained (Ferre´-D’Amare´ and Doudna, 2000; Ferre´-
D’Amare´ et al., 1998; Rupert and Ferre´-D’Amare´, 2001).
All of these methods have utility, but in general each is
suitable for a subset of RNAs. Thus, the process of obtain-
ing a derivative remains a key bottleneck in the process of
solving RNA crystal structures.
We set out to develop a general strategy to derivatize
RNA crystals with reagents readily purchased or made
and without the additional step of synthesizing and crys-
tallizing modified RNA. We based our strategy on the
proven power of trivalent hexammine complex ions to761–772, July 2007 ª2007 Elsevier Ltd All rights reserved 761
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wavelength anomalous diffraction (MAD or SAD) methods
and their inherent affinity for RNA. In the last few years
multiple structures have been solved using cobalt (III)
hexammine, iridium (III) hexammine, or osmium (III) hex-
ammine ions (examples in Batey et al., 2004; Cate et al.,
1996; Cochrane et al., 2007; Kazantsev et al., 2005; Mon-
tange and Batey, 2006; Pfingsten et al., 2006), suggesting
that if the ions can be positioned rationally and specifically
in a crystallized RNA, phases can be obtained. Rationally
positioning heavy atoms in this way is analogous to
a method developed by protein crystallographers in the
late 1980s in which the ‘‘soak and pray’’ technique was
improved by using site-directed mutagenesis to specifi-
cally introduce cysteines that bind mercury atoms in a
‘‘directed soak’’ approach (Stock et al., 1989; Sun et al.,
1987).
Toward the goal of reliably positioning hexammine ions
in RNA we used the GUwobble pair motif (Masquida and
Westhof, 2000; Varani and McClain, 2000), which creates
a pocket for cation binding in themajor groove that is lined
by partially negatively charged RNA functional groups
(Figure 1A). Versions of this motif bind hexammine com-
plexes (Cate and Doudna, 1996; Colmenarejo and Tinoco,
1999; Kieft and Tinoco, 1997; Montange and Batey, 2006;
Stefan et al., 2006), and thus we reasoned that this inher-
ent affinity could be used to engineer a hexammine bind-
ing site into any RNA helix. However, it was clear from
a survey of many different RNA structures that not all ver-
sions of the GU pair motif bind cations equally well
(A.Y.K. and J.S.K., data not shown), which is likely why
this motif has not been used for routine rational localiza-
tion of cations. Thus, the practical use of GU pairs to lo-
calize a heavy atom required that we determine the rules
of the interactions and identify the optimal motif version
for this purpose.
We performed a detailed crystallographic analysis of
hexammine complex binding to the GU motif using
a strategy in which a ‘‘crystallization chassis’’ was
employed to solve the structures of thirteen different motif
variants. Comparison of these structures allowed us to
identify versions that recruit a hexammine ion with high
occupancy and order. Combined with the appropriate
cations, this results in a phasing strategy that uses readily
available reagents, does not require separate crystalliza-
tion of a derivatized RNA, can be adapted to some RNA
crystals grown in very high salt concentrations, is fully
integrated with existing RNA crystallography methods,
and can be used to obtain phase information from both
synchrotron and rotating copper anode (‘‘at-home’’) radi-
ation. This strategy has resulted in the determination of
three novel RNA structures, proving it to be a robust
means of acquiring phase information.
RESULTS
Design and Use of a Crystallization Chassis
A heavy-atom site that is useful for phasing is one in which
the occupancy of the site is high and the B factor (mea-762 Structure 15, 761–772, July 2007 ª2007 Elsevier Ltd All righsurement of the motion of the cation) is low; thus, our first
goal was to determine the GU motif features that affect
these characteristics. We hypothesized that both the
orientation of the GU pairs (in tandem pairs) and the
flanking base pairs are important determinants of high-
order, high-occupancy cation binding. To test these ideas,
we needed to systematically crystallize different motif
variants while maintaining nearly identical crystallization
conditions. We therefore developed a crystallization chas-
sis that consisted of the RNA/M-domain protein complex
from the E. coli signal recognition particle (SRP) solved to
high resolution by Batey and colleagues (Batey et al.,
2000, 2001). In addition, examination of this complex in
the presence of various cations showed it accommodates
a variety of metal ions without structural changes (Batey
and Doudna, 2002). In this structure most crystal contacts
are mediated by the protein and GAAA tetraloop; the P1
helix stacks only loosely on the helix of an adjacent mole-
cule (Figures 1B and 1C). This suggested we could insert
virtually any GU-containing sequence into this helix (box,
Figure 1C) and obtain crystals. This approach is preferable
to crystallizing multiple, small, isolated RNA helices with
different versions of the GU motif because each of those
helices represents a unique crystallization target, requiring
optimization of different crystallization conditions.
We chose the trivalent cation cobalt (III) hexammine as
our probe for several reasons. First, it is readily observed
in the electron density and distinguished from other
ligands (such as water). Second, the cobalt atom scatters
anomalously at the wavelength of Cu-Ka X-rays generated
by a rotating copper anode (f00 = 3.608 e) and thus we
could analyze the anomalous signal without synchrotron
radiation. Third, cobalt (III) hexammine has been observed
to bind to the same sites as iridium (III), osmium (III), or rho-
dium (III) hexammine (Cate and Doudna, 1996; Cate et al.,
1996; Ennifar et al., 2003). Fourth, the SRP RNA/M-
domain crystallization chassis has been crystallized with
cobalt (III) hexammine and this structure provides a start-
ing point for our analysis (Batey and Doudna, 2002).
Lastly, the ion is commercially available and inexpensive.
The issue of whether hexammines are good mimics for
hexahydrated magnesium is not of importance here.
Figure 1C shows the sixteen sequenceswe inserted into
the crystallization chassis, including tandem and single
GU pairs. Each row of Figure 1C contains variants of
the motif in which the orientation of the GU pairs is
changed, and each column contains versions in which
the orientation of one or both of the G-C flanking
sequences is changed. Using the crystallization chassis,
we were able to crystallize thirteen of the sixteen variants
in similar conditions. The crystals had the same space
group and similar unit cell dimensions and morphologies.
Inserting GU Pairs Creates a Cation Binding Site
The first structure we solved was PM04 (Figure 1C), and
examination of this structure illustrates the success and
utility of the crystallization chassis. In the crystallization
chassis containing the unmutated SRP RNA (no engi-
neered GU sites) that was soaked with cobalt (III)ts reserved
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General RNA Crystal Phasing StrategyFigure 1. The Use of GU Pairs and the Crystallization Chassis
(A) Schematic of a canonical RNA G-C base pair and a GU wobble pair. The GU pair places partially negative charges in the major groove, forming
a pocket for cation binding.
(B) Diagram of intermolecular packing in the crystal of the SRP RNA-M domain previously reported (Batey et al., 2000, 2001). The end of RNA helix
P1 (black) stacks on P1 from an adjacent molecule (gray) in a fairly loose intermolecular contact (boxed). No other crystal contacts are made by this
portion of the RNA.
(C) The structure of the SRP RNA-M domain complex is shown on the left with the mutated helix. In the middle is a schematic of this complex. The
protein binding site is shown in gray and the hashed box denotes the portion involved in the majority of crystal contacts. The solid box is the portion of
the P1 helix that is displayed by this crystallization chassis and which was mutated into the various sequences shown at right.hexammine (Batey and Doudna, 2002), there are two cat-
ions localized near the phosphate backbone on opposite
sides of the helix (Figure 2A), but none at this location in
the major groove. When this helix is mutated to contain
two tandem GU pairs (PM04) the two sites are replaced
by a single area of electron density in the major groove
at the wobble pairs (Figure 2B). The identity of these sites
as cobalt (III) hexammine ions was verified using anoma-Structure 15lous difference Fourier maps (Figure 2C). Hence, we
were able to engineer and display a new major groove
cation binding site in the RNA, demonstrating that the
chassis could be used to examine more motif variants.
Criteria for Judging the Quality of a Binding Site
There is an endogenous cobalt (III) hexammine binding
site at tandem GU pairs located away from our site of, 761–772, July 2007 ª2007 Elsevier Ltd All rights reserved 763
Structure
General RNA Crystal Phasing StrategyFigure 2. Engineered Cation Binding
(A) Electron density and structure of the wild-type SRP RNA-M domain complex, showing the portion of the helix that was varied. The view is into the
major groove. Two cobalt (III) hexammine ions (magenta) are located near the phosphate backbone (upper right site) and two adjacent G-C pairs
(lower left).
(B) Electron density and structure of the variant PM04, with the tandem wobble pairs shown in cyan and the resultant major groove-bound cobalt (III)
hexammine in magenta.
(C) Anomalous difference Fourier map (contoured at 7 s in red) of PM04 superimposed on the structure. The tandem wobble pairs are shown in cyan.
The endogenous reference site is at the top, and the new engineered site at the bottom.
(D) Comparison of the very well-ordered reference site to the new site in PM04 in a 2Fo  Fc map, at 2 A˚ resolution, contoured at 2 s.mutation, containing a high-occupancy well-ordered cat-
ion (Figure 2D) that was unchanged by mutagenesis.
Comparing the electron density of this endogenous site
to the engineered site of PM04 clearly shows differences.
Specifically, the endogenous site is so highly ordered that
the ammine ligands are well oriented with respect to the
RNA, whereas the engineered site appears elongated
without defined ammine density. This endogenous site is
a good internal control to standardize the information
from each engineered site. To judge each engineered
site against this internal control site, we established two
criteria. The first is the B factor of the engineered site
divided by the B factor of the existing reference site
(Brel). Since the B factor reflects the degree of order of
the cation, this measure compares localization of the
cobalt (III) hexammine in each motif variant. The second
criterion is the relative size of the anomalous difference
peak associated with the engineered site in an anomalous
difference Fourier map (Anomrel), which reflects both the
order and occupancy of the site. Hence, bound cations
with lower Brel and higher Anomrel are the most useful for
phasing. As an example, the Brel of the engineered site
of PM04 (Figure 2B) is 1.54 and Anomrel is 0.74, which is
the fifth largest peak in the map (Table 1).764 Structure 15, 761–772, July 2007 ª2007 Elsevier Ltd All rigTandem GU Pairs: Position and Localization
of the Cation
We solved the structures of seven versions of the tandem
GUmotif (see Figure S1 and Table S1 in the Supplemen-
tal Data available with this article online), revealing the
effects of changing the orientation of the tandem pairs
as well as the flanking sequences (Figure 3A). Changing
the orientation of the tandem GU pairs changes the loca-
tion of the cobalt (III) hexammine in the binding pocket and
in some cases allows binding of a second cobalt (III)
hexammine just next to the pocket. This occurs because
the positioning of groups within the pocket changes with
the relative orientation of the GU pairs. In cases where
the U bases were in the 50 positions (e.g., PM02, PM06),
the pocket geometry was such that the hexammine com-
plex is moved substantially relative to its position in other
motif variants. However, although the relative orientation
of the GU pairs alters the position of the cation, it does
not substantially alter its Brel or Anomrel (Table 1), indicat-
ing little change in the site occupancy or order.
Changing the orientation of a flanking pair is different
than changing the orientation of the GU pairs
(Figure S1) in that the primary effect is not to move the
cation, but to increase the degree of cation order andhts reserved
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PM01 GGGC/GUUC 25.1% 28.3% 1.84 0.65 5
PM02 GUGC/GUGC 24.5% 27.2% 1.36 0.48 7
PM03d GUUC/GGGC 24.5% 44.4% — — —
PM04 GGUC/GGUC 23.4% 27.3% 1.54 0.74 5
PM05 GGGG/CUUC 26.8% 31.2% 1.19 0.78 2
PM06 GUGG/CUGC 27.7% 31.4% 1.55 0.46 11
PM07d GUUC/CGGC 31.2% 35.5% — — —
PM08 GGUG/CGUC 27.8% 31.3% 1.14 1.06 1
PM09 CGGG/CUUG 23.8% 26.0% 1.46 0.56 4
PM10e CUGG/CUGG — — — —
PM11e CUUG/CGGG — — — —
PM12e CGUG/CGUG — — — —
Single GU Pairs
PM13 GGG/CUC 23.2% 26.9% 1.16 0.94 3
PM14 GGC/GUC 29.2% 34.1% 1.22 0.86 3
PM15f CUG/CGG 22.3% 24.5% 1.15 0.67 3
PM16g GUG/CGC 26.3% 31.4% — — —
aRwork = S jjFoj  jFcjj/SjFoj, Rwork from the working set and Rfree from the test set (10% of the data).
b Relative B = B factor of engineered site/B factor of reference site.
c Relative anom. signal = height of engineered site peak in anomalous difference Fourier map/height of reference site peak in anom-
alous difference Fourier map.
d These constructs yielded crystals of poorer quality and thus were not included in our analyses or submitted to the PDB.
e These constructs failed to crystallize.
f Values given are for the site closest to the binding pocket.
g No hexammine was observed in the binding pocket.occupancy as reflected in Brel and Anomrel (Table 1).
These observations demonstrate that the overall nature
of the binding pocket and its usefulness as part of a phas-
ing strategy depends on the orientation of both GU pairs
and flanking pairs, and hence the motif comprises four
base pairs.
Cation Localization: The Effect of Caging Amines
The observation that the orientation of flanking base pairs
affects cation localization is likely due to major groove
RNA amine groups. In the variants examined here, this
amine group is supplied by a cytosine of the flanking pairs,
but could also be supplied by an adenine. In PM01-
PM04, the cytosine is in a 30 position in relation to the
cation binding pocket, and thus is withdrawn from the
pocket by the turn of the helix. In PM05-PM08, one cyto-
sine is placed 50 to the tandem pairs, moving an amine
group into a prominent position in the major groove. This
electropositive amine repels the cation, possibly caging
it on one side and limiting its movement in the pocket.
This is illustrated by comparing PM01 to PM05
(Figure 3A and 4A). In PM01, the ion is mobile as itStructure 15attempts to satisfy potential hydrogen bonding partners
from not only the tandem GU pairs, but also from the
two flanking pairs (Figure 4A), an effect also evident in
the elongated density of the engineered site of PM04
(Figure 2B). In PM05, the motion of the ion is restricted
possibly due to the major groove amine placed on one
side of the binding site (Figure 4A), reducing its Brel. Based
on this reasoning, placing two major groove amines 50 to
the tandem pairs should result a very well-ordered cation,
but alternate crystal packing of PM09 and the failure of
PM10, 11, and 12 to crystallize prevented us from directly
testing this (Figure S1).
Binding to Single GU Pairs
To examine the ability of a single GU wobble pair to bind
hexammine compounds, we crystallized variants PM13-
PM16 (Figure 1C), examining the effects of both the ori-
entation of the single wobble and flanking pairs
(Figure S2 and Table S2). Only two effectively bound an
ion, but in both cases the site was of high order and high
occupancy (as judged by Brel and Anomrel, Table 1).
Thus, single GU pairs are more sensitive to flanking, 761–772, July 2007 ª2007 Elsevier Ltd All rights reserved 765
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in Selected Variants of the Motif
(A) Comparison of cobalt (III) hexammine bind-
ing in the major groove of three representative
motif variants. Major groove carbonyls of the
wobble GU pairs and the flanking Watson-
Crick pairs are shown in red, N7 nitrogens are
shown in orange, and cytosine amines are
shown in blue. The location of bound hexam-
mine ions is shown in green. The sequence of
each variant is shown above the structure
with boxes denoting the difference when com-
pared to PM01. PM01 and PM02 differ in the
relative orientation of their tandem GU pairs,
which moves the cation in the site. Both are
examples of poor sites for localizing a hexam-
mine. PM05 differs from PM01 by the orienta-
tion of a flanking pair, and it is an example of
a good site with high occupancy and a high
degree of cation localization (low Brel and
high Anomrel, Table 1). Structures of the other
tandem GU pairs are contained in Figure S1.
(B) Comparison of two representative single
GU pair-containing sequences. The se-
quence of each variant is shown above the
structure with boxes denoting the difference
when compared to PM13. PM14 contains
a very good site, while PM16 has no hexam-
mine in the pocket. Colors are the same as
(A). Structures of the other two single GU
pair-containing sequences are in Figure S2.sequence and disruptions in the pocket shape than are
tandem GU pairs, likely due to the smaller overall size
of the binding pocket. In single GU pairs the uracil of
the wobble pair is best followed by an amine-containing
nucleotide (Figure 4B). This withdraws the amines from
the major groove and allows sufficient room for cation
binding. In the case of PM15, the uracil carbonyl of the
GU extends into the major groove and disrupts the
pocket, similar to PM02 and PM06 (Figures S1 and S2).
Hence, useful binding into single GUpairs are the reverse
of those for tandem pairs: in tandem pairs we hypothesize
that 50 amines cage and localize the cation, while in single
pairs these amines exclude the cation (Figures 3B and 4B).
An Optimal Single GU Pair and Hexammines
Define the Method
The detailed analysis of thirteen structures identifies that
both PM13 and PM14 are good versions of the motif for
use as a hexammine complex binding site. We pursued
PM14 for further analyses and experimentation, which is
a single GU pair with the following sequence: 50-GUC-
30/50-GGC-30 or 50-UUA-30/50-UGA-30 (Figures1C and
3B). Both the Brel and Anomrel, for a hexammine bound
in this site are among the best. In addition, a single GU
pair motif has the advantage of being a three base pair
motif (compared to four base pairs for tandem pairs),
requiring a smaller sequence change to the helix when
introduced.
This single wobble pair motif and readily available
hexammines are combined to yield a general strategy766 Structure 15, 761–772, July 2007 ª2007 Elsevier Ltd All rigfor obtaining a derivative crystal and phase information.
First, one or more helices in the RNA are identified that
are conserved in terms of formation, but not conserved
in terms of sequence. Second, these helices are mutated
to introduce the optimal motif, which requires at most
a change to three base pairs of the RNA and does not alter
formation of the helix. The RNA is cocrystallized with
5 mM hexammine cations or the cations are soaked
into the crystal during cryo-protection, resulting in the
high-occupancy, tightly constrained binding of a hexam-
mine ion used to obtain phase information.
Demonstrated Successes of the Phasing Strategy
The true test of this phasing method and its general appli-
cability is if it can be used to solve novel RNA structures.
As of this writing, several novel crystal structures have
been solved using this phasing strategy, succeeding in
one case when multiple other methods failed.
The first example is the SAM-1 riboswitch RNA, the
structure of which was solved during the development of
our phasing method (Montange and Batey, 2006; Gilbert
et al., 2006). A single optimal motif (50-UUA-30/50-UGA-30)
was inserted into one helix and another single GU pair
that does not conform to the rules was inserted into an-
other helix. Crystals of this RNA were grown in the pres-
ence of iridium (III) hexammine to yield the derivative
used to solve the structure using MAD phasing with syn-
chrotron radiation. Examination of the location of the hex-
ammine complexes in the structure shows that a cation
bound strongly to the optimal site but none was observedhts reserved
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General RNA Crystal Phasing StrategyFigure 4. General Rules for Cation Bind-
ing in the Major Groove of GU Motifs
(A) Schematic of the arrangement of major
groove functional groups for PM01, PM05,
and PM09. These three variants vary only in
the orientation of flanking G-C pairs relative
to the tandem GU pairs. Blue circles are
amine, red are carbonyls, and orange are
purine N7 groups. In PM01, the two major
groove amines (from cytosine) are placed
away from the binding site due to the turn of
the helix. In PM05 and PM09, the amines are
placed in position to limit the mobility of the
ion (shown in green). In addition, the location
of carbonyls and N7 groups in the flanking
sequences and close to the binding site make
the ion more mobile as it attempts to satisfy
multiple potential hydrogen binding partners.
(B) Schematic of the arrangement of major
groove functional groups in the four single
GU pair containing variants. In single GU
pairs, the amines are best placed in the
30 positions to withdraw them from the pocket.in thenonoptimal site,matchingour predictions. This same
preferential binding of iridium (III) hexammine in an optimal
site, but not another site, was observed in a recent struc-
ture of the GlmS riboswitch/ribozyme (J.C. Cochrane,
S.V. Lipchock, and S.A. Strobel, personal communica-
tion). Furthermore, the anomalous signal provided from
the ‘‘directed soak’’ of this hexammine ion into an engi-
neered site on theSAM-1 riboswitchwascritical for solving
the structure, as illustrated by an examination of anoma-
lous difference Patterson maps (Figure S3).
Another example involved a situation where this phas-
ing method might be predicted to fail. In this case, the
crystals grew in and required very high salt conditions
(e.g., >2 M Li2SO4), a condition in which the high [Li
+] is
expected to compete trivalent ions out of all binding sites.
We also observed low solubility of the hexammine
complexes in the high sulfate (data not shown) suggesting
covalently modified RNAs were needed to obtain a deriva-
tive. To solve the phase problem, we tried traditional soak-
ing methods, uniform and partial bromouracil incorpora-
tion, molecular replacement using model A-form RNA
helices (Robertson and Scott, 2007), and SAD phasing
using the phosphorus anomalous signal from a chromium
rotating anode source (Dauter, 2002; Dauter and Ada-
miak, 2001), but we were unable to obtain phase informa-
tion from any of these methods.
To solve this structure, we inserted the optimal motif
into an RNA helix and took advantage of the high solubility
of the acetate salts of iridium (III) hexammine and cobalt
(III) hexammine (Lindholm, 1978). We exchanged the solu-
tion in steps from 2 M Li2SO4 to 3 M LiAcetate + 0.1 M
hexammine acetate (both cobalt and iridium complexes
were used). The high concentration of hexammine com-
plex allowed it to compete for the binding site, and the
high salt preserved and cryoprotected the crystal. WeStructure 15, 7were then able to solve the structure, first using cobalt
(III) hexammine and then independently using iridium (III)
hexammine, both of which revealed a very well-ordered
hexammine ion located in the engineered site. This struc-
ture will be presented in another manuscript (D.A. Costan-
tino, R.P.R, and J.S.K., unpublished data).
Using the Phasing Strategy to Solve Structures
‘‘At Home’’
Phasing methods that use anomalous signal (MAD, SAD)
almost always require synchrotron radiation. However,
the ability to use cobalt atoms with anomalous scattering
(1.61 A˚) near the Ka energy of typical ‘‘at-home’’ rotating
copper anode X-ray sources (1.54 A˚) was demonstrated
for RNA (Batey et al., 2004) and recently demonstrated
for proteins (Guncar et al., 2007). To test if this method
might be more generally applied and integrated with our
phasing strategy, we used the RNA crystals grown in high
salt described above and collected a dataset using Cu-
Ka radiation. Using the program PHENIX to conduct auto-
mated SAD phasing and density modification, we located
three cobalt (III) hexammine sites and obtained a prelimi-
nary interpretable electron density map (Figure 5A). This
map was then improved using iridium (III) hexammine-
soaked crystals and synchrotron radiation (Figure 5B).
The same high-order, high-occupancy heavy-atom sites
were found in both iridium and cobalt complexes.
As a second test, we used the dataset from PM15
(soaked with cobalt (III) hexammine) collected with Cu-
Ka radiation and calculated phases using SAD and density
modification. The resultant experimental electron density
map rivals or exceeds the quality of maps obtained from
synchrotron radiation and MAD phasing (Figure 5C).
Hence, our phasing method may allow routine phasing
of RNA crystals using typical ‘‘at-home’’ X-ray sources.61–772, July 2007 ª2007 Elsevier Ltd All rights reserved 767
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General RNA Crystal Phasing StrategyFigure 5. Experimental Electron Density of RNAs Phased Using ‘‘At-Home’’ and Synchrotron Radiation
(A) Experimental electron density of the ‘‘high salt’’ crystal described in the text, obtained using diffraction data collected with an ‘‘at-home’’ X-ray
source andSADphasing froma cobalt (III) hexammine derivative. In red is anRNAmodel placed in the density. The asterisk denotes density of a cobalt
(III) hexammine. This density is not ideal, but is clearly RNA.
(B) Experimental electron density of exactly the same RNA in (A), but phased at a synchrotron using MAD data and iridium (III) hexammine. Again, the
red shows placed RNA and the asterisks denote two bound iridium (III) hexammines. When compared to (A), the density is greatly improved.
(C) Experimental electron density of the SRPRNA/M-domain complex using diffraction data collected with an ‘‘at-home’’ X-ray source and SAD phas-
ing from a cobalt (III) hexammine derivative. In red is RNA placed in the density. Although this electron density was obtained using only SAD data from
a rotating anode and cobalt (III) hexammine, the density rivals that obtained from synchrotron radiation and MAD phasing.The Use of Different Heavy-Atom Cations
The optimal single GU motif can also bind some, but not
all, other heavy atoms. Recently, the motif was used with
cesium atoms to solve the structure of a novel RNA using
an ‘‘at-home’’ Cu-Ka X-ray source and SIRAS phasing
(Figure S4), demonstrating the utility of this commercially
available cation (S.D. Gilbert, R.P.R., D. Van Tyne, and
R.T.B., unpublished data). In addition, the locations of
the cesiums allowed unambiguous placement of multiple
copies of the RNA into the asymmetric unit. In contrast,
divalent barium ions did not bind in the engineered GU
motif of the SAM-1 riboswitch RNA (Montange and Batey,
2006), demonstrating that not all cations are suitable for
this phasing strategy. We have not conducted a compre-
hensive survey of cations binding to this site, but our
results show that both commercially available cobalt (III)
hexammine (trivalent) and cesium (monovalent) can be
used, as can synthesized iridium (III) hexammine.
DISCUSSION
Obtaining experimental phase information is a critical step
in solving macromolecular structures by X-ray crystallog-
raphy, generally requiring specifically bound heavy atoms.
For protein crystallography, uniform incorporation of sele-
nomethionine residues during bacterial expression makes
protein crystallography available to a broad range of users
(Doublie, 1997; Hendrickson et al., 1990). For RNA, no
analogous method has been available, for although RNA
can be covalently modified with heavy atoms, there are
limitations to this and to soaking heavy-atom cations
into the crystals (Golden, 2000, 2007). To address this
gap, we have identified a simple and reliable means to
localize one or more heavy atoms suitable for phasing to
virtually any RNA target. This directed soak approach,
based on a single GU pair motif combined with various
heavy-atom cations, facilitates routine phasing of RNA768 Structure 15, 761–772, July 2007 ª2007 Elsevier Ltd All rigcrystal data using both rotating anode and synchrotron
radiation.
The phasing method we present here is essentially con-
structed from two pieces of knowledge: GU pairs can
bind cations in the major groove (Cate and Doudna,
1996; Colmenarejo and Tinoco, 1999; Kieft and Tinoco,
1997;Masquida andWesthof, 2000;Montange andBatey,
2006; Stefan et al., 2006; Varani and McClain, 2000) and
hexammine complexes provide good heavy-atom deriva-
tives of RNA crystals for phasing (Batey et al., 2004; Cate
et al., 1996; Cochrane et al., 2007; Kazantsev et al., 2005;
Montange and Batey, 2006; Pfingsten et al., 2006). How-
ever, before this knowledge could be used, the detailed
rules that govern binding in different versions of the motif
had to be explored and the optimal sequence discovered.
Now, the phasing strategy presented here can be
integrated fully into existing RNA crystallography method-
ology (Figure 6). Because current RNA crystallization
strategies employ systematic variation of the RNA con-
struct guided by biochemical and functional studies to
yield a library of RNA to be screened for crystals (Cate
and Doudna, 2000; Golden, 2007; Golden and Kundrot,
2003; Ke and Doudna, 2004; Wedekind and McKay,
2000), the most useful way to use this method is to antic-
ipate the need for a derivative at the initial stages of RNA
construct design and insert the optimal GU motif into
one or more helices of all RNAs made. When crystals
are obtained, the heavy-atom derivative is prepared by
adding 5 mM of hexammine ion to the crystal during
cryo-protection, or cocrystallizing the RNA and hexam-
mine. The commercial availability and low cost of cobalt
(III) hexammine chloride allows it to be a standard reagent
in crystallization trials. For high salt conditions, themethod
of moving the crystals to an acetate salt and 100–150 mM
hexammine acetate can be attempted. Hence, in this
integrated approach there is no separate step of synthe-
sizing or purifying derivatized RNA, of mutating or altering
the RNA, or of soaking in a variety of different heavyhts reserved
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conditions may be necessary.
The integrated strategy can be extended to obtain
phase information ‘‘at home’’ using crystals that contain
the single GU motif and either cobalt (III) hexammine or
cesium. If a usable map is obtained, building of the struc-
ture can begin. Even if a usable map is not obtained, the
presence of specifically bound heavy atoms can be
detected from the anomalous signal, the location of the
sites may be obtained, and the likelihood of success using
iridium (III) hexammine and synchrotron radiation can be
assessed.
The size of a given RNA and the availability of appropri-
ate helices will place constraints on the number of sites
that can be introduced into the RNA. However, the poten-
tial usefulness of introducing even a small number of high-
occupancy heavy-atom sites is illustrated by the SAM-1
riboswitch structure (Montange and Batey, 2006). In this
30.5 kD RNA, one strong engineered iridium (III) hexam-
mine site and three weak fortuitous sites were sufficient
to yield an interpretable map. Similar results were
observed with the structure of the ribosome binding do-
main of an IRES RNA (Pfingsten et al., 2006). These obser-
vations lead us to hypothesize that a strong, highly occu-
pied site can provide the ‘‘anchor’’ for finding other
Figure 6. Flowchart of the Phasing Strategy Integrated into
Existing RNA Crystallography Methods
Black boxes represent a standard methodology for producing diffract-
ing RNA crystals and solving their structures, starting with design and
purification of many different variants for use in crystallization screens.
Our method integrates into this pathway (red boxes) without adding
additional steps.Structure 15,weaker, naturally occurring sites. In all of the structures
we have solved using this method, fortuitous lower-occu-
pancy sites in the RNA helped phase, but in many cases
these sites are weak enough (occupancy < 0.4) that they
may not work on their own. Support for this idea comes
from examining the experimental and predicted Patterson
maps of the SAM-1 riboswitch iridium (III) hexammine de-
rivatives (Figure S3). In the absence of a strong site, peaks
from a collection of weaker sites (occupancy = 0.4) recede
into the noise, but when a strong site is present (occu-
pancy = 1) all peaks become usable. The number of sites
needed to solve a given RNA structure is likely to depend
on the RNA size, the heavy atom used, the X-ray source
(Cu-Ka/synchrotron), and the experimental method
(SAD/MAD/SIRAS).
EXPERIMENTAL PROCEDURES
Crystallization Chassis RNA Preparation
All sixteen PM constructs were cloned from a plasmid containing the
sequence for the wild-type E. coli SRP RNA that was crystallized
previously (Batey et al., 2000, 2001). Sequences were inserted into
a pUC19 vector with a hepatitis d ribozyme at the 30 end and a hammer-
head ribozyme at the 50 end to ensure homogeneity (Ferre´-D’Amare´
and Doudna, 1996). DNA templates for transcription were generated
by PCR from these plasmids and used in transcription reactions using
T7 RNA polymerase. The conditions were: 40 mM Tris-HCl (pH 8.1),
1 mM spermidine, 5 mM dithiothreitol, 0.01% Triton X-100, 60 mM
MgCl2, 8 mM each ribonucleotide triphosphate (pH adjusted to 8.0)
and 0.04 mg/ml T7 RNA polymerase. The reactions incubated at
37C overnight, then were placed at 65C for 5min to ensure complete
cleavage of the ribozymes. The reaction was then precipitated by
adding 4 volumes of ice-cold 100% ethanol. The resulting pellet was
resuspended in 4.5 M urea loading buffer. The RNA was purified by
gel electrophoresis on a 10% denaturing polyacrylamide gel in
1X TBE buffer. The band containing the RNA was visualized by UV-
shadowing, excised from the gel, crushed, and allowed to elute into
RNase-free H2O overnight, with shaking at 4
C. The gel pieces were
filtered out of the solution using a 0.22 mm filter (Nalgene). The RNA
then was concentrated using a centrifugal filter with a 10,000 molecu-
lar weight cutoff (Amicon).
Crystallization of the Crystallization Chassis
E. coli M-domain protein was prepared as described (Batey et al.,
2000, 2001). For each RNA construct, the exact amount of M-domain
protein needed for crystallization was determined using a native gel
electrophoresis assay as described (Batey et al., 2001). Briefly, RNA
at 30–40 mM was titrated with varying dilutions of protein in 10 mM
Tris-HCl (pH 7.5), 5 mM MgCl2, 100 mM KCl, 1 mM dithiothreitol,
and 50 mM NaCl. The reaction was allowed to incubate for 20 min,
and then electrophoresed through 8% native polyacrylamide gels
with 0.53 TBE and 2 mM MgCl2. The gels were run at 7 W for 1 hr
and stained with ethidium bromide to visualize the free RNA and
RNA protein complex. From the native gels, amount of protein needed
to achieve 1:1 stoichiometry was determined. A molar ratio of 0.98:1
protein:RNA was then combined to form the RNA-protein complexes
for crystallography. The complex was denatured with 1 ml of 8 M
urea and then dialyzed against 10 mM K-HEPES (pH 7.5) overnight
at 4C. The complex was concentrated in a 10,000 MWCO microcon-
centrator (Amicon) to approximately 700 mM. Crystals were grown by
vapor diffusion with sitting drops at 20C using 2 ml of the renatured
protein-RNA complex and 2 ml of the reservoir solution which con-
tained 8%–13% isopropanol, 50 mM Na-MES (pH 5.6), 200 mM KCl,
and 3–6 mM cobalt (III) hexammine. Crystals grew in 1–3 d and were761–772, July 2007 ª2007 Elsevier Ltd All rights reserved 769
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solution + 30% (v/v) MPD, then cryo-cooled in liquid nitrogen.
Crystallization Chassis Data Collection and Processing
Diffraction data for all constructs were collected using a rotating anode
copper X-ray source and Raxis IV++ detector (Rigaku-MSC) under
cryo-conditions. We collected a full 360 of data in 30 wedges using
an inverse beam strategy with an oscillation width of 1 per frame.
Exposure times were from 10–20 min per frame. Data were indexed,
integrated, and scaled using d*trek (Pflugrath, 1999) and converted
to files suitable for use in CNS (Brunger et al., 1998).
Crystallization Chassis Molecular Replacement
and Structure Refinement
Model phases were obtained for each dataset using the wild-type
SRP/M-domain complex (PDB code: 1DUL) (Batey et al., 2000) with
all cations removed as a search model for molecular replacement
with the program CNS (Brunger et al., 1998). For each complex, an
unambiguous solution was found and the resultant electron density
maps contained clear density for the cobalt (III) hexammines, and
these were added manually to the model. The identity and location
of the cobalt (III) hexammines were confirmed using anomalous differ-
ence Fourier maps calculated in CNS (Brunger et al., 1998) as shown in
Figure 2. The model then was changed to introduce the correct GU
pair sequence and the RNA/protein/hexammine model was refined
in CNS using iterative rounds of simulated annealing, energy minimiza-
tion, and B factor refinement (Brunger et al., 1998).
Phasing of SRP RNA/M-Domain Complex Using
Cu-Ka Radiation
Experimental phases were obtained by integrating and scaling the
data from crystal PM15 in HKL2000 (Otwinowski and Minor, 1997).
Scaling was done with the ‘‘no merge original index’’ macro enabled.
The raw data were used with the AUTOSOL SAD function of the pro-
gram PHENIX (Adams et al., 2002, 2004), with thorough density mod-
ification (solvent content set at 0.5) and the data flagged as ‘‘weak.’’
This procedure located 12 heavy-atom sites (overall FOM = 0.21).
Preparation of Iridium (III) Hexammine Chloride
The iridium hexammine was prepared according to methods outlined
in the literature (Cruse et al., 2001; Galsbøl and Simonsen, 1990).
Two grams iridium chloride (IrCl3) (Aldrich) and 35 ml ammonium
hydroxide were added to a heavy-walled ACE pressure tube (Aldrich)
(Cruse et al., 2001). The tube was then sealed and incubated in
a 150C silicone oil bath for four days (Cruse et al., 2001; Galsbøl
and Simonsen, 1990). The reaction then was allowed to completely
cool and incubated on slushy ice. The clear, light brown solution
then was filtered and evaporated to dryness under vacuum. While
evaporating, the solution was heated to 50C using a water bath (Gals-
bøl and Simonsen, 1990). The resulting solid then was resuspended in
5 ml of water and transferred to a 50 ml conical tube. Two milliliters of
concentrated HCl then was added to the solution. Precipitate was
spun down in a centrifuge and the light yellow supernatant was
discarded. Pellet was washed three times with 10 ml of a 2:1 (v/v)
water:conc. HCl solution by vigorous vortexing followed by centrifuga-
tion. Supernatant was discarded after each wash. The pellet was then
washed three times in absolute ethanol, air-dried, and resuspended in
3 ml ddH2O (Cruse et al., 2001). Solution was centrifuged one more
time to remove insoluble material. The resulting supernatant should
show a clear absorbance maxima at 251 nm and concentration can
be calculated using the extinction coefficient 92 M1cm1 at 251 nm
(Galsbøl and Simonsen, 1990). Typical yield is 50%. Supernatant
then was aliquoted into fresh Eppendorf tubes and stored at 20C.
Preparation of Hexammine Acetates from Chloride Salts
Cobalt (III) hexammine acetate was prepared from cobalt (III) hexam-
mine chloride (Sigma) using a simple precipitation procedure. Hexam-
mine chloride (0.6675 g) was dissolved in 25 ml water (100 mM) in770 Structure 15, 761–772, July 2007 ª2007 Elsevier Ltd All righta 50 ml conical tube and to this was added 1.42 g lead acetate (Sigma)
dissolved in 5 ml water. The lead chloride immediately precipitated,
and the solution was allowed to sit for 30 min to ensure complete
precipitation. The precipitated material was spun down and the super-
natant (containing dissolved hexammine acetate) was removed and
concentrated/crystallized by passive evaporation. The hexammine
acetate was harvested by dissolving the crystals in 5 ml of water, yield-
ing a stock solution of 500 mM cobalt (III) hexammine acetate.
Iridium (III) hexammine was prepared by adding 0.0535 g of lead
acetate to 0.5ml of 188mM iridium (III) hexammine chloride andmixing
well. The resultant solution was allowed to sit on the bench for 30 min,
after which time the precipitated lead chloride was spun down in a
microcentrifuge and the hexammine acetate salt solution was re-
moved. The solution then was concentrated by passive evaporation
in a crystallization tray and the dry crystals were collected and stored
at 20C until use.
Transfer of Crystals into High Salt/High Hexammine Conditions
The ‘‘high salt’’ RNA crystals described in the text grew in 1.4MLi2SO4,
40 mM MgAcetate, 50 mM HEPES-NaOH (pH 7.5), 0.5 mM spermi-
dine-HCl via vapor diffusion/hanging drop (D.A. Costantino, R.P.R.,
and J.S.K., unpublished data). To transfer these crystals into the
acetate salt, the crystals first were stabilized by replacing the well
solution with 2.0 M Li2SO4, 40 mM MgAcetate, 50 mM HEPES-
NaOH (pH 7.5), 0.5 mM spermidine-HCl. The well was resealed and
the crystallization drop allowed to equilibrate overnight. The crystals
were then transferred to a soaking tray containing 50 ml of 2.0 M
Li2SO4, 40 mM MgAcetate, 50 mM HEPES-NaOH (pH 7.5), 0.5 mM
spermidine-HCl (well solution). The crystals were allowed to sit undis-
turbed for 10 min, at which time 50 ml of solution ‘‘10%’’ was added to
the soak. Solution ‘‘10%’’ contained 90 ml of well solution + 10 ml of
3.0 M lithium acetate, 40 mM MgAcetate, 50 mM HEPES-NaOH
(pH 7.5), 0.5 mM spermidine-HCl, 100 mM iridium hexammine acetate
(derivative solution). The crystals soaked for 10min, at which time 50 ml
of the soaking solution were removed and 50 ml of solution ‘‘20%’’ was
added (‘‘20%’’ = 80 ml well solution +20 ml derivative solution) and the
crystal was allowed to soak for 10 min. This process was repeated as
the concentration of derivative solution was stepped up in 10% incre-
ments, until the crystals had been moved into 100% derivative solu-
tion. The crystals were washed several times with this solution before
soaking for 1 additional hour and then were cryo-cooled directly in liq-
uid nitrogen.
High-Salt Crystal Data Collection, Processing, and Phasing
The details of this structure and its determination will be presented in
another manuscript (D.A. Costantino, R.P.R., and J.S.K., unpublished
data).
Cesium-Derivatized Crystal Data Collection, Processing,
and Phasing
The details of this structure and its determination will be presented in
another manuscript (S.D. Gilbert, R.P.R., D. Van Tyne, and R.T.B.,
unpublished data).
Supplemental Data
Supplemental data include four figures and two tables of crystallo-
graphic data and can be found with this paper online at http://www.
structure.org/cgi/content/full/15/7/761/DC1/.
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